Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FSVYB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $58,471
Award facts
- Contract value 100% obligated
- $58,470.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $58,470.80 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania.
This award is a child order under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The prime contract serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the company to deliver a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Dupixent, a biologic medication used in dermatological and immunological conditions, represents the type of specialty pharmaceutical product that AmerisourceBergen supplies through this strategic relationship with the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FSVYB?
SPE2DB25FSVYB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FSVYB worth?
The government has obligated $58,471 on SPE2DB25FSVYB.
Is contract SPE2DB25FSVYB an order under another contract?
Yes. SPE2DB25FSVYB is a delivery order under SPE2DB25D7067, an indefinite delivery contract.
Was contract SPE2DB25FSVYB competed?
The extent of competition for SPE2DB25FSVYB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award